Benitec Biopharma (BLT)
Benitec Biopharma Ltd. engages in the development of therapeutics based on patented gene-silencing technology called ddRNAi or RNAi. It operates through the Australia and United States of America geographical segments. The company was founded by Kenneth C. Reed in 1997 and is headquartered in Melbourne, Australia.
|Market Price at 22-11-2017||$0.20|
|Price to Earnings Ratio||-3.86|
|Market Capitalisation||$40.00 (million)|
|Return on Equity (ROE)||-26.41%|